{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:23:33Z","timestamp":1778509413670,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,7]]},"DOI":"10.7759\/cureus.21014","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T17:36:21Z","timestamp":1641576981000},"source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Graves' Disease Associated With Severe Neutropenia"],"prefix":"10.7759","author":[{"given":"Soukaina","family":"Laidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Motaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloua","family":"Elamari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Anajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Chadli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves' disease","volume":"343","author":"Weetman AP","year":"2000","unstructured":"Weetman AP. Graves' disease. N Engl J Med. 2000, 343:1236-48. 10.1056\/NEJM200010263431707","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer Y","year":"2014","unstructured":"Tomer Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol. 2014, 9:147-56. 10.1146\/annurev-pathol-012513-104713","journal-title":"Annu Rev Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0015","article-title":"Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms","volume":"29","author":"Huber A","year":"2008","unstructured":"Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008, 29:697-725. 10.1210\/er.2008-0015","journal-title":"Endocr Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper DS","year":"2005","unstructured":"Cooper DS. Antithyroid drugs. N Engl J Med. 2005, 352:905-17. 10.1056\/NEJMra042972","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0178","article-title":"Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases","volume":"92","author":"Laurberg P","year":"2007","unstructured":"Laurberg P, Vestergaard H, Nielsen S, Christensen SE, Seefeldt T, Helleberg K, Pedersen KM. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. J Clin Endocrinol Metab. 2007, 92:2149-56. 10.1210\/jc.2007-0178","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0085","article-title":"The long-term outcome of treatment for Graves' hyperthyroidism","volume":"29","author":"Sj\u00f6lin G","year":"2019","unstructured":"Sj\u00f6lin G, Holmberg M, T\u00f6rring O, et al.. The long-term outcome of treatment for Graves' hyperthyroidism. Thyroid. 2019, 29:1545-57. 10.1089\/thy.2019.0085","journal-title":"Thyroid"},{"key":"ref8","article-title":"Ein Fall von malignem Morbus Basedowii kombiniert mit den Symptomen der Pseudoleukamie","volume":"54","author":"Caro L","year":"1907","unstructured":"Caro L. Ein Fall von malignem Morbus Basedowii kombiniert mit den Symptomen der Pseudoleukamie. Berl Klin Wochenschr. 1907, 54:519-23.","journal-title":"Berl Klin Wochenschr"},{"key":"ref9","article-title":"Blutuntersuchungen bei morbus Basedowii mit Beitragen ur Frudiagnose und Theorie der Krankheit","volume":"87","author":"Kocher T","year":"1908","unstructured":"Kocher T. Blutuntersuchungen bei morbus Basedowii mit Beitragen ur Frudiagnose und Theorie der Krankheit. Arch Kin Chir. 1908, 87:131.","journal-title":"Arch Kin Chir"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13133","article-title":"Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease","volume":"85","author":"Aggarwal N","year":"2016","unstructured":"Aggarwal N, Tee SA, Saqib W, Fretwell T, Summerfield GP, Razvi S. Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease. Clin Endocrinol (Oxf). 2016, 85:949-53. 10.1111\/cen.13133","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2478\/jomb-2019-0004","article-title":"Can neutrophil\/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism?","volume":"39","author":"Da\u011fdeviren M","year":"2020","unstructured":"Da\u011fdeviren M, Akkan T, Yapar D, Karakaya S, Da\u011fdeviren T, Ertu\u011frul D, Altay M. Can neutrophil\/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism?. J Med Biochem. 2020, 39:7-12. 10.2478\/jomb-2019-0004","journal-title":"J Med Biochem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000886","article-title":"High frequency of thyroid disorders in patients presenting with neutropenia to an outpatient hematology clinic STROBE-compliant article","volume":"94","author":"Kyritsi EM","year":"2015","unstructured":"Kyritsi EM, Yiakoumis X, Pangalis GA, et al.. High frequency of thyroid disorders in patients presenting with neutropenia to an outpatient hematology clinic STROBE-compliant article. Medicine (Baltimore). 2015, 94:e886. 10.1097\/MD.0000000000000886","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.64.756.735","article-title":"The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis","volume":"64","author":"Ford HC","year":"1988","unstructured":"Ford HC, Carter JM. The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad Med J. 1988, 64:735-42. 10.1136\/pgmj.64.756.735","journal-title":"Postgrad Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111663","article-title":"Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils","volume":"75","author":"Weitzman SA","year":"1985","unstructured":"Weitzman SA, Stossel TP, Harmon DC, Daniels G, Maloof F, Ridgway EC. Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils. J Clin Invest. 1985, 75:119-23. 10.1172\/JCI111663","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2013.113","article-title":"Relationship between leukopenia and intercellular adhesion molecules in Graves' disease","volume":"63","author":"Gao Y","year":"2014","unstructured":"Gao Y, Shen HJ, Zhou P, Hu H, Tang JL, Peng LL, Tong J. Relationship between leukopenia and intercellular adhesion molecules in Graves' disease. West Indian Med J. 2014, 63:601-4. 10.7727\/wimj.2013.113","journal-title":"West Indian Med J"},{"key":"ref16","article-title":"Changes of granulocyte distribution induced by thyroxin and epinephrine: experiment with rabbits. (Article in Chinese)","volume":"88","author":"Tong J","year":"2008","unstructured":"Tong J, Fu YS, Hao HJ, et al.. Changes of granulocyte distribution induced by thyroxin and epinephrine: experiment with rabbits. (Article in Chinese). Zhonghua Yi Xue Za Zhi. 2008, 88:2826-8.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14313","article-title":"Neutropenia in patients with hyperthyroidism: systematic review and meta-analysis","volume":"94","author":"Scappaticcio L","year":"2021","unstructured":"Scappaticcio L, Maiorino MI, Maio A, Esposito K, Bellastella G. Neutropenia in patients with hyperthyroidism: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2021, 94:473-83. 10.1111\/cen.14313","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI100471","article-title":"The blood picture in exophthalmic goitre and its changes resulting from iodine and operation. A study by means of the supravital technique","volume":"11","author":"Hertz S","year":"1932","unstructured":"Hertz S, Lerman J. The blood picture in exophthalmic goitre and its changes resulting from iodine and operation. A study by means of the supravital technique. J Clin Invest. 1932, 11:1179-96. 10.1172\/JCI100471","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13398","article-title":"Graves' disease with severe neutropenia: any clues?","volume":"87","author":"Hegazi MO","year":"2017","unstructured":"Hegazi MO, Almansour A, Nawara A. Graves' disease with severe neutropenia: any clues?. Clin Endocrinol (Oxf). 2017, 87:408-9. 10.1111\/cen.13398","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79885-treatment-of-graves-disease-associated-with-severe-neutropenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:13Z","timestamp":1707507313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79885-treatment-of-graves-disease-associated-with-severe-neutropenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.21014","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,7]]}}}